Goldman Sachs Call 120 ABT 15.11..../ DE000GG9XET0 /
13/11/2024 11:29:45 | Chg.-0.002 | Bid18:39:18 | Ask18:39:18 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.006EUR | -25.00% | 0.003 Bid Size: 20,000 |
0.023 Ask Size: 20,000 |
Abbott Laboratories | 120.00 USD | 15/11/2024 | Call |
GlobeNewswire
06/08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
15/03
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
14/11/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
19/10/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer